June 17, 2026: This month, Across the Consortium highlights the clinical research contributions Big Ten cancer centers made during the American Society of Clinical Oncology (ASCO) Annual Meeting as well as some unique research programs that are paving the way for future clinical breakthroughs. In addition, we celebrate significant milestones across the Big Ten, from NCI designation renewal to new collaborations that will change the course of clinical care.

But first, we are pleased to annouce registration is now open for the Big Ten CRC Summit on Friday, October 2. Register at: bigtencrc.org/summit.

Read More

April 21, 2026: In this edition of Across the Consortium, we pause to recognize recent significant milestones and research accomplishments by our member institutions. From a prestigious NCI designation that will accelerate research advances from the lab to the clinic, to grant funding that will transform the way health care is delivered around the world, to research awards that will help early-career investigators launch new avenues for discovery, and due honor for those whose work has influenced international guidelines, there is much to celebrate from New Brunswick to Seattle and all points between. Read More

February 19, 2026: In this month’s Across the Consortium, The Big Ten Cancer Research Consortium highlights the innovation, discovery, and impact happening across our member institutions. From novel therapies to tools that guide personalized care, this issue highlights the wide-range of research and initiatives across Big Ten Cancer Research Consortium member institutions, all aimed at improving prevention, detection, and treatment for cancer patients. Read More

February 3, 2026:

The Big Ten Cancer Research Consortium is pleased to announce Cristina Truica, MD, as a new member of the Big Ten CRC Steering Committee. Dr. Truica is a medical oncologist at Penn State Cancer Institute and has been an active member of the Big Ten CRC breast cancer working group for more than a decade. Read More

January 22, 2026:

As we look back on the past year, I want to extend my sincere appreciation to our investigators, 16 member institutions, leadership teams, research staff, and partners across the Big Ten Cancer Research Consortium. Read More

January 2, 2026:

A Big Ten CRC study, BTCRC-GI21-500, will be presented as a Trials in Progress poster at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026 in San Francisco. This study is led by Ashish Manne, MBBS, of The Ohio State University. Read More

December 23, 2025:

In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights the innovation, discovery, and impact happening across our member institutions. From novel therapies to community-focused initiatives, this issue showcases the depth of research that drives progress in cancer prevention, detection, and treatment throughout our member institutions. Read More

December 5, 2025:

A Big Ten Cancer Research Consortium clinical trial, BTCRC-BRE15-024, titled “A phase I/II, single arm, nonrandomized study of ribociclib, a CDK 4/6 inhibitor, in combination with bicalutamide, an androgen receptor inhibitor, in advanced AR-positive triple-negative breast cancer,” (SABCS Poster # PS5-02-26) will be presented by Julia Knight-Shefner, MD, of the University of Wisconsin Carbone Cancer Center, as a poster at the 2025 San Antonio Breast Cancer Symposium. Read More

November 19, 2025:

The Big Ten Cancer Research Consortium is pleased to announce William P. Harris, MD, as a new member of the Big Ten CRC Steering Committee. Dr. Harris is a board-certified medical oncologist at Fred Hutchinson Cancer Center and UW Medical Center and serves as an associate professor in the Division of Hematology and Oncology at the University of Washington. Read More

December 2, 2025:

A Big Ten CRC clinical trial, BTCRC-LUN18-363, titled, “Chemo-immunotherapy followed by durvalumab and ceralasertib in treatment naïve patients with extensive-stage small cell lung cancer,” led by Muhammad Furqan, MD, formerly of the University of Iowa, was featured as a proffered paper presentation at the European Society for Medical Oncology (ESMO) 2025 Congress in Berlin.  Read More